Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole for outpatient COVID-19
IRCT20201124049480N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of levamisole in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: General condition of the patient, Admission and 11 more. Started Apr 2021; status: completed.
02
Drugs
levamisole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201124049480N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201124049480N1.